Eastman Chemical Company (EMN) has experienced a range of market performances, with stock often underperforming in comparison to rivals, yet on other days outperforming competitors. The organization's Q1 and Q3 earnings lagged behind estimates, while sales exceeded estimates. Significant stock purchases were made by HSBC Holdings and Corient Private Wealth. Donald Slager joined the company's board of directors. Although the company missed earnings expectations for Q1 2024, their financial outlook was publicly shared. Recently, the company also made strides in innovation, with new sustainable plasticizers coming to market. Amidst macroeconomic challenges in 2023, the company maintained healthy cash flow. The company also revealed its pricing for a cash tender offer for all 5.500% notes due. EMN continues to be a popular choice amongst institutional investors, boasting of 84% ownership. More specifically, Eastmans has demonstrated resilience within its industry and provided respectable returns to its investors over the past five years. It's also considered a strong dividend stock, although it saw a 23.3% decrease since its last earnings report.
Eastman Chemical Company EMN News Analytics from Tue, 05 Sep 2023 07:00:00 GMT to Sun, 02 Jun 2024 14:23:49 GMT -
Rating 3
- Innovation -6
- Information 7
- Rumor 5
